What top creators are saying about Agios Pharmaceuticals, Inc.(AGIO)
Biopharmaceutical company with a focus on thalassemia after a setback in its sickle cell program.
3 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Agios Pharmaceuticals, Inc..
Top creators covering Agios Pharmaceuticals, Inc. (AGIO)
The 1 sources with the most insights about Agios Pharmaceuticals, Inc. on Kazuha.
Latest insights about Agios Pharmaceuticals, Inc. (AGIO)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, July 21, 2026
Down 20% earlier but shrugged off, host bought expecting rebound, short-term price-action trade.
Thursday, November 20, 2025
Considered 'pretty undervalued' with strong fundamentals, an approved drug, and a large cash position. However, the host sold his position to lock in profits after a quick rally from $22 to $25.
Wednesday, November 19, 2025
The speaker views the stock's 50% drop due to bad sickle cell data as a buying opportunity, believing the market has overreacted and the company is undervalued based on its cash and existing drugs.
Tuesday, July 21, 2026
Down 20% earlier but shrugged off, host bought expecting rebound, short-term price-action trade.
Thursday, November 20, 2025
Considered 'pretty undervalued' with strong fundamentals, an approved drug, and a large cash position. However, the host sold his position to lock in profits after a quick rally from $22 to $25.
Wednesday, November 19, 2025
The speaker views the stock's 50% drop due to bad sickle cell data as a buying opportunity, believing the market has overreacted and the company is undervalued based on its cash and existing drugs.
Discussed alongside Agios Pharmaceuticals, Inc. (AGIO)
Other assets that creators frequently mention in the same content as Agios Pharmaceuticals, Inc..
Frequently asked
Which podcasters and creators cover Agios Pharmaceuticals, Inc. (AGIO) the most?
The most active sources covering Agios Pharmaceuticals, Inc. (AGIO) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Agios Pharmaceuticals, Inc. (AGIO) are on Kazuha?
Kazuha has indexed 3 AI-extracted insights about Agios Pharmaceuticals, Inc. (AGIO) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Agios Pharmaceuticals, Inc. (AGIO)?
Creators covering Agios Pharmaceuticals, Inc. (AGIO) most frequently also discuss PLTR, BHVN, NVDA, BTC, OLMA. See the "Discussed alongside" section above for full asset pages.